Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults
Although a minority of asthma patients suffer from severe asthma, they represent a major clinical challenge in terms of poor symptom control despite high-dose treatment, risk of exacerbations, and side effects. Novel biological treatments may benefit patients with severe asthma, but are expensive, a...
Published in: | European Clinical Respiratory Journal |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , |
Other Authors: | , |
Format: | Review |
Language: | English |
Published: |
Co-Action Publishing
2019
|
Subjects: | |
Online Access: | http://hdl.handle.net/10138/299404 |
id |
ftunivhelsihelda:oai:helda.helsinki.fi:10138/299404 |
---|---|
record_format |
openpolar |
spelling |
ftunivhelsihelda:oai:helda.helsinki.fi:10138/299404 2024-06-09T07:47:12+00:00 Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults Porsbjerg, Celeste Ulrik, Charlotte Skjold, Tina Backer, Vibeke Laerum, Birger Lehman, Sverre Janson, Crister Sandstrom, Thomas Bjermer, Leif Dahlen, Barbro Lundback, Bo Ludviksdottir, Dora Bjornsdottir, Unnur Altraja, Alan Lehtimaki, Lauri Kauppi, Paula Karjalainen, Jussi Kankaanranta, Hannu Faculty of Medicine HUS Inflammation Center 2019-02-23T15:47:01Z 20 application/pdf http://hdl.handle.net/10138/299404 eng eng Co-Action Publishing 10.1080/20018525.2018.1440868 Porsbjerg , C , Ulrik , C , Skjold , T , Backer , V , Laerum , B , Lehman , S , Janson , C , Sandstrom , T , Bjermer , L , Dahlen , B , Lundback , B , Ludviksdottir , D , Bjornsdottir , U , Altraja , A , Lehtimaki , L , Kauppi , P , Karjalainen , J & Kankaanranta , H 2018 , ' Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults ' , European Clinical Respiratory Journal , vol. 5 , 1440868 . https://doi.org/10.1080/20018525.2018.1440868 ORCID: /0000-0002-1065-330X/work/159452413 http://hdl.handle.net/10138/299404 7caaf935-7a1f-4671-98d7-d960f5fb89d7 000427092300001 cc_by info:eu-repo/semantics/openAccess openAccess Asthma severe prevalence diagnosis co-morbidities management guideline SEVERE ALLERGIC-ASTHMA PLACEBO-CONTROLLED TRIAL QUALITY-OF-LIFE GASTROESOPHAGEAL-REFLUX DISEASE RANDOMIZED CONTROLLED-TRIAL OBSTRUCTIVE SLEEP-APNEA VOCAL CORD DYSFUNCTION CLINICAL-PRACTICE GUIDELINE SEVERE UNCONTROLLED ASTHMA TO-TREAT ASTHMA 3121 General medicine internal medicine and other clinical medicine Review Article publishedVersion 2019 ftunivhelsihelda 2024-05-14T23:40:59Z Although a minority of asthma patients suffer from severe asthma, they represent a major clinical challenge in terms of poor symptom control despite high-dose treatment, risk of exacerbations, and side effects. Novel biological treatments may benefit patients with severe asthma, but are expensive, and are only effective in appropriately targeted patients. In some patients, symptoms are driven by other factors than asthma, and all patients with suspected severe asthma ('difficult asthma') should undergo systematic assessment, in order to differentiate between true severe asthma, and 'difficult-to-treat' patients, in whom poor control is related to factors such as poor adherence or co-morbidities. The Nordic Consensus Statement on severe asthma was developed by the Nordic Severe Asthma Network, consisting of members from Norway, Sweden, Finland, Denmark, Iceland and Estonia, including representatives from the respective national respiratory scientific societies with the aim to provide an overview and recommendations regarding the diagnosis, systematic assessment and management of severe asthma. Furthermore, the Consensus Statement proposes recommendations for the organization of severe asthma management in primary, secondary, and tertiary care. Peer reviewed Review Iceland HELDA – University of Helsinki Open Repository Norway European Clinical Respiratory Journal 5 1 1440868 |
institution |
Open Polar |
collection |
HELDA – University of Helsinki Open Repository |
op_collection_id |
ftunivhelsihelda |
language |
English |
topic |
Asthma severe prevalence diagnosis co-morbidities management guideline SEVERE ALLERGIC-ASTHMA PLACEBO-CONTROLLED TRIAL QUALITY-OF-LIFE GASTROESOPHAGEAL-REFLUX DISEASE RANDOMIZED CONTROLLED-TRIAL OBSTRUCTIVE SLEEP-APNEA VOCAL CORD DYSFUNCTION CLINICAL-PRACTICE GUIDELINE SEVERE UNCONTROLLED ASTHMA TO-TREAT ASTHMA 3121 General medicine internal medicine and other clinical medicine |
spellingShingle |
Asthma severe prevalence diagnosis co-morbidities management guideline SEVERE ALLERGIC-ASTHMA PLACEBO-CONTROLLED TRIAL QUALITY-OF-LIFE GASTROESOPHAGEAL-REFLUX DISEASE RANDOMIZED CONTROLLED-TRIAL OBSTRUCTIVE SLEEP-APNEA VOCAL CORD DYSFUNCTION CLINICAL-PRACTICE GUIDELINE SEVERE UNCONTROLLED ASTHMA TO-TREAT ASTHMA 3121 General medicine internal medicine and other clinical medicine Porsbjerg, Celeste Ulrik, Charlotte Skjold, Tina Backer, Vibeke Laerum, Birger Lehman, Sverre Janson, Crister Sandstrom, Thomas Bjermer, Leif Dahlen, Barbro Lundback, Bo Ludviksdottir, Dora Bjornsdottir, Unnur Altraja, Alan Lehtimaki, Lauri Kauppi, Paula Karjalainen, Jussi Kankaanranta, Hannu Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults |
topic_facet |
Asthma severe prevalence diagnosis co-morbidities management guideline SEVERE ALLERGIC-ASTHMA PLACEBO-CONTROLLED TRIAL QUALITY-OF-LIFE GASTROESOPHAGEAL-REFLUX DISEASE RANDOMIZED CONTROLLED-TRIAL OBSTRUCTIVE SLEEP-APNEA VOCAL CORD DYSFUNCTION CLINICAL-PRACTICE GUIDELINE SEVERE UNCONTROLLED ASTHMA TO-TREAT ASTHMA 3121 General medicine internal medicine and other clinical medicine |
description |
Although a minority of asthma patients suffer from severe asthma, they represent a major clinical challenge in terms of poor symptom control despite high-dose treatment, risk of exacerbations, and side effects. Novel biological treatments may benefit patients with severe asthma, but are expensive, and are only effective in appropriately targeted patients. In some patients, symptoms are driven by other factors than asthma, and all patients with suspected severe asthma ('difficult asthma') should undergo systematic assessment, in order to differentiate between true severe asthma, and 'difficult-to-treat' patients, in whom poor control is related to factors such as poor adherence or co-morbidities. The Nordic Consensus Statement on severe asthma was developed by the Nordic Severe Asthma Network, consisting of members from Norway, Sweden, Finland, Denmark, Iceland and Estonia, including representatives from the respective national respiratory scientific societies with the aim to provide an overview and recommendations regarding the diagnosis, systematic assessment and management of severe asthma. Furthermore, the Consensus Statement proposes recommendations for the organization of severe asthma management in primary, secondary, and tertiary care. Peer reviewed |
author2 |
Faculty of Medicine HUS Inflammation Center |
format |
Review |
author |
Porsbjerg, Celeste Ulrik, Charlotte Skjold, Tina Backer, Vibeke Laerum, Birger Lehman, Sverre Janson, Crister Sandstrom, Thomas Bjermer, Leif Dahlen, Barbro Lundback, Bo Ludviksdottir, Dora Bjornsdottir, Unnur Altraja, Alan Lehtimaki, Lauri Kauppi, Paula Karjalainen, Jussi Kankaanranta, Hannu |
author_facet |
Porsbjerg, Celeste Ulrik, Charlotte Skjold, Tina Backer, Vibeke Laerum, Birger Lehman, Sverre Janson, Crister Sandstrom, Thomas Bjermer, Leif Dahlen, Barbro Lundback, Bo Ludviksdottir, Dora Bjornsdottir, Unnur Altraja, Alan Lehtimaki, Lauri Kauppi, Paula Karjalainen, Jussi Kankaanranta, Hannu |
author_sort |
Porsbjerg, Celeste |
title |
Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults |
title_short |
Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults |
title_full |
Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults |
title_fullStr |
Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults |
title_full_unstemmed |
Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults |
title_sort |
nordic consensus statement on the systematic assessment and management of possible severe asthma in adults |
publisher |
Co-Action Publishing |
publishDate |
2019 |
url |
http://hdl.handle.net/10138/299404 |
geographic |
Norway |
geographic_facet |
Norway |
genre |
Iceland |
genre_facet |
Iceland |
op_relation |
10.1080/20018525.2018.1440868 Porsbjerg , C , Ulrik , C , Skjold , T , Backer , V , Laerum , B , Lehman , S , Janson , C , Sandstrom , T , Bjermer , L , Dahlen , B , Lundback , B , Ludviksdottir , D , Bjornsdottir , U , Altraja , A , Lehtimaki , L , Kauppi , P , Karjalainen , J & Kankaanranta , H 2018 , ' Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults ' , European Clinical Respiratory Journal , vol. 5 , 1440868 . https://doi.org/10.1080/20018525.2018.1440868 ORCID: /0000-0002-1065-330X/work/159452413 http://hdl.handle.net/10138/299404 7caaf935-7a1f-4671-98d7-d960f5fb89d7 000427092300001 |
op_rights |
cc_by info:eu-repo/semantics/openAccess openAccess |
container_title |
European Clinical Respiratory Journal |
container_volume |
5 |
container_issue |
1 |
container_start_page |
1440868 |
_version_ |
1801378136679514112 |